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Patrick M. Honore* and Herbert D. SpapenSee related research by Krajčová et al., http://ccforum.biomedcentral.com/articles/10.1186/s13054-015-1112-5We read with interest the comprehensive review of
Krajčová et al. [1] on propofol infusion syndrome
(PRIS). Of particular importance is the high (51 %!)
associated mortality which is mainly determined by
cardiac failure, therapy-resistant bradyarrhythmia, meta-
bolic acidosis, and rhabdomyolysis [1]. The authors provide
a detailed insight on the pathophysiologic mechanism(s)
underlying PRIS but do not discuss therapy, probably be-
cause therapeutic options are limited and merely support-
ive. Basically, propofol should be withdrawn immediately
and adequate hemodynamic support must be ensured. Pa-
tients who develop rhabdomyolysis-associated acute kidney
injury (AKI) are treated with hemodialysis or hemofiltra-
tion. Extracorporeal membrane oxygenation was life-saving
in two patients [2]. A recent case report described rapid
hemodynamic improvement and resolution of lactic
acidosis after one single session of plasma exchange [3].
We suggest that early initiation of continuous renal
replacement therapy (CRRT), even in the absence of
well-established indications such as AKI, metabolic acid-
osis, or hyperkalemia, might add a survival benefit. Propofol
undergoes hepatic metabolization and is rapidly cleared by
the kidneys as propofol-glucuronide and 2,6-diisopropyl-
1,4-quinol sulfo- and glucuro-conjugates [4]. Unlike the
highly lipophilic parent drug, these toxic water-soluble me-
tabolites can be eliminated by CRRT. Caution is needed,
however, when implementing such a strategy. Prolonged
PRIS-related cardiogenic shock with severely compromised
hepatic and muscle perfusion may dramatically reduce
mitochondrial citrate metabolism and result in citrate accu-
mulation. As citrate is increasingly used for regional antic-
oagulation during CRRT, tight monitoring of the ionized/
total calcium ratio is imperative to obviate metabolic com-
plications related to citrate intoxication. A ratio exceeding* Correspondence: Patrick.Honore@az.vub.ac.be
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(http://creativecommons.org/publicdomain/ze2.25 strongly suggests citrate overdose and requires re-
placing citrate by unfractionated heparin [5].
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